brand logo

Am Fam Physician. 2016;94(11):880-881

Author disclosure: No relevant financial affiliations.

Clinical Question

Is the Mini-Mental State Examination (MMSE) useful in detecting dementia in clinically unevaluated patients 65 years and older?

Evidence-Based Answer

When scores are adjusted based on a patient's education level, the MMSE may be useful to rule out a diagnosis of dementia in clinically unevaluated patients 65 years and older (sensitivity = 97%; specificity = 70%). Scores of less than 24 may also be useful to rule in dementia in patients 65 years and older (sensitivity = 85%; specificity = 90%). These patients warrant further evaluation. There is insufficient evidence to recommend a specific score on the MMSE to confidently rule out or rule in dementia in patients 65 years and older.1 (Strength of Recommendation: B, based on inconsistent or limited-quality patient-oriented evidence.)

Practice Pointers

Although the estimated prevalence of dementia ranges from 5% to 37% in U.S. adults older than 70 years, as many as 29% to 76% may go undiagnosed by their primary care physicians.2 The MMSE is a 30-point scale, with lower numbers equating to more severe impairment. It was originally used to characterize the severity of cognitive impairment and to monitor that severity over time.3 However, the MMSE and similar tests of cognition are also used in primary care as part of the initial evaluation of patients with suspected dementia.4

This Cochrane review is a meta-analysis of 28 community-based studies with 12,110 patients and six primary care studies with 1,681 patients.1 Community-based studies conducted mass screening of asymptomatic persons in a public-health format. All the patients in the studies were 65 years and older.

In the community-based studies, a score of less than 24 on the MMSE was 85% sensitive (95% confidence interval [CI], 74% to 92%) and 90% specific (95% CI, 82% to 95%) for dementia. Adjusting the score for education level yielded a higher sensitivity of 97% (95% CI, 83% to 100%) but a lower specificity of 70% (95% CI, 50% to 85%). When screening 1,000 asymptomatic persons, of whom 140 have dementia, and using a cutoff adjusted for education level, four persons with dementia would be missed and 258 would be subjected to further testing. If an unadjusted score of less than 24 were used in the same population, 21 persons with dementia would be missed, but 86 would be subjected to further testing.

The MMSE is one of a number of available tests to evaluate cognitive performance as part of a dementia evaluation.4 The Montreal Cognitive Assessment tool (MoCA) is also a one-page, 30-point scale that is gaining favor over the MMSE because of its greater sensitivity for mild cognitive impairment with less educational, language, and cultural bias.5 The MoCA is not copyrighted, whereas use of the MMSE is copyright restricted. The Diagnostic and Statistical Manual of Mental Disorders, 5th ed., suggests formal neuropsychological testing when available, allowing for less extensive testing if formal testing is not available, without providing a recommendation on any specific cognitive assessment tools.6 A formal diagnosis of dementia requires that cognitive performance be interpreted in the context of the patient's current condition, including symptomatology, progression, impact on daily living, and a search for other causes (e.g., delirium, depression, medication effect).4

The U.S. Preventive Services Task Force found insufficient evidence to recommend for or against screening based on the lack of evidence for improved decision making by the patient, family, or caregiver, and societal outcomes were not improved with earlier detection.2 Despite this recommendation, the Medicare annual wellness visit requires cognitive screening, but it does not provide specific guidance on the appropriate evaluation of patients who screen positive. The Medicare Detection of Cognitive Impairment Workgroup, convened by the Alzheimer's Association, recommends a stepwise approach in which one or more cognitive assessment tools, such as the MMSE, are a step or component in the evaluation.7 This Cochrane review supports the conclusion that the MMSE may be useful to help screen for dementia, but it should not be used in isolation to diagnose the disease.1

The practice recommendations in this activity are available at

editor's note: The MMSE had been freely available and widely disseminated after first being released in 1975. However, starting in 2000, its authors (Dr. Folstein and others) began enforcing their copyright, and in 2001 arranged for Psychological Assessment Resources (PAR) to manage worldwide rights. PAR insists that all users register with their site, complete a four-page permissions request form, and pay a fee for each MMSE form and its use (approximately $1.35), as well as purchase a test manual ($78) [Costs as of October 2016].

This commercialization of a cognitive screening test seems antithetical to the advancement of science and the practice of medicine. Until the MMSE's copyright holders abandon this practice, clinicians should know that there are alternatives to the MMSE, including the Saint Louis University Mental Status (SLUMS) examination, which has been shown to be more sensitive than the MMSE:

The views expressed herein are those of the authors and do not reflect the official policy of the Department of the Army/Navy/Air Force, the Department of Defense, or the U.S. government.

These are summaries of reviews from the Cochrane Library.

This series is coordinated by Corey D. Fogleman, MD, assistant medical editor.

A collection of Cochrane for Clinicians published in AFP is available at

Continue Reading

More in AFP

More in PubMed

Copyright © 2016 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.